Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Publication year range
1.
Mol Med Rep ; 16(5): 6828-6836, 2017 Nov.
Article in English | MEDLINE | ID: mdl-28901489

ABSTRACT

Hypoxic preconditioning (HPC) is well­known to exert a protective effect against hypoxic injury; however, the underlying molecular mechanism remains unclear. The present study utilized a serum metabolomics approach to detect the alterations associated with HPC. In the present study, an animal model of HPC was established by exposing adult BALB/c mice to acute repetitive hypoxia four times. The serum samples were collected by orbital blood sampling. Metabolite profiling was performed using ultra­performance liquid chromatography­quadrupole time­of­flight mass spectrometry (UPLC­QTOFMS), in conjunction with univariate and multivariate statistical analyses. The results of the present study confirmed that the HPC mouse model was established and refined, suggesting significant differences between the control and HPC groups at the molecular levels. HPC caused significant metabolic alterations, as represented by the significant upregulation of valine, methionine, tyrosine, isoleucine, phenylalanine, lysophosphatidylcholine (LysoPC; 16:1), LysoPC (22:6), linoelaidylcarnitine, palmitoylcarnitine, octadecenoylcarnitine, taurine, arachidonic acid, linoleic acid, oleic acid and palmitic acid, and the downregulation of acetylcarnitine, malate, citrate and succinate. Using MetaboAnalyst 3.0, a number of key metabolic pathways were observed to be acutely perturbed, including valine, leucine and isoleucine biosynthesis, in addition to taurine, hypotaurine, phenylalanine, linoleic acid and arachidonic acid metabolism. The results of the present study provided novel insights into the mechanisms involved in the acclimatization of organisms to hypoxia, and demonstrated the protective mechanism of HPC.


Subject(s)
Chromatography, High Pressure Liquid , Hypoxia , Spectrometry, Mass, Electrospray Ionization , Amino Acids/blood , Animals , Discriminant Analysis , Disease Models, Animal , Ischemic Preconditioning , Least-Squares Analysis , Lysophosphatidylcholines/blood , Male , Metabolomics , Mice , Mice, Inbred BALB C , Palmitoylcarnitine/blood , Principal Component Analysis
2.
Sci Rep ; 6: 22589, 2016 Mar 04.
Article in English | MEDLINE | ID: mdl-26940428

ABSTRACT

The exposure of healthy subjects to high altitude represents a model to explore the pathophysiology of diseases related to tissue hypoxia. We explored a plasma metabolomics approach to detect alterations induced by the exposure of subjects to high altitude. Plasma samples were collected from 60 subjects both on plain and at high altitude (5300 m). Metabolite profiling was performed by gas chromatography-mass spectrometry (GC-MS) and ultra-performance liquid chromatography-quadrupole time-of-flight mass spectrometry (UPLC-QTOFMS) in conjunction with univariate and multivariate statistical analyses. ELISA assays were further employed to measure the levels of several relevant enzymes together with perturbed metabolic pathways. The results showed that hypobaric hypoxia caused significant and comprehensive metabolic changes, as represented by significant changes of 44 metabolites and 4 relevant enzymes. Using MetaboAnalyst 3.0, it was found that several key metabolic pathways were acutely perturbed. In addition, 5 differentially expressed metabolites in pre-exposure samples from the acute mountain sickness-susceptible (AMS-S) group compared with those from the AMS-resistant (AMS-R) group are identified, which warrant further validation as potential predictive biomarkers for AMS-S individuals. These results provide new insights for further understanding the pathophysiological mechanism of early acclimatization to hypobaric hypoxia and other diseases correlated to tissue hypoxia.


Subject(s)
Adaptation, Physiological , Altitude Sickness/diagnosis , Biomarkers/blood , Blood Proteins/metabolism , Hypoxia/diagnosis , Acute Disease , Disease Susceptibility , Gas Chromatography-Mass Spectrometry , Humans , Male , Metabolic Networks and Pathways , Metabolomics , Prognosis , Young Adult
3.
Zhongguo Gu Shang ; 29(9): 782-786, 2016 Sep 25.
Article in Chinese | MEDLINE | ID: mdl-29282944

ABSTRACT

OBJECTIVE: To study clinical treatment effects of inactivating myofascial trigger points with needling and muscle stretching for the treatment of knee osteoarthritis(OA). METHODS: Retrospective analyses were made to investigate the clinical data of pain clinic outpatient in our hospital from 2010 to 2014, and 108 patients with knee OA, including 35 males and 73 females, were treated with acupuncturing of myofascial trigger points and stretching of muscles and structure around knee. The puncturing of trigger points, and the back and forth movement of needle were required to elicit local twitch response of muscle. After acupuncture treatment, muscle stretch around the knee joint was performed by a therapist. All patients must do homework of self stretching exercise. The extent of stretching should be to gradually increased under a tolerable pain. The ROM and walking pain VAS scores were measured before and after whole therapy and were statistically analyzed during 1 year of follow up. RESULTS: All the patients were followed up, and 95 patients had no pain after 1 year. The VAS scores were improved from preoperative severe 7.6±0.5, moderate 4.9±0.7, to mild 1.9±0.6 and painless 0.3±0.2. CONCLUSIONS: The walking pain of knee OA might be alleviated by the acupuncture and stretch to inactivate the myofascial trigger point.


Subject(s)
Acupuncture Therapy , Myofascial Pain Syndromes/therapy , Osteoarthritis, Knee/therapy , Trigger Points , Female , Humans , Male , Muscle Stretching Exercises , Retrospective Studies , Treatment Outcome
4.
Clin Nucl Med ; 38(5): 375-7, 2013 May.
Article in English | MEDLINE | ID: mdl-23567283

ABSTRACT

A 63-year-old man with papillary thyroid carcinoma (PTC) and bone metastases was treated with 131I residual thyroid ablation (RTA) and 2 repeated post-ablation 131I therapies after total thyroidectomy. 131I whole-body scans (WBS) demonstrated sustained and diffuse 131I avid bone metastases, accompanied by persistent very low thyroglobulin (Tg) levels and negative antithyroglobulin antibody (TgAb) in post-ablation 131I therapies in hypothyroid state after levothyroxine withdrawal. The spread of bone metastases were found on the last therapeutical 131I WBS. The benefit of 131I therapy after levothyroxine withdrawal should be weighed even if the metastases are 131I avid in poorly differentiated thyroid carcinoma.


Subject(s)
Bone Neoplasms/diagnostic imaging , Bone Neoplasms/secondary , Carcinoma/pathology , Thyroglobulin/blood , Thyroid Neoplasms/pathology , Bone Neoplasms/blood , Bone Neoplasms/metabolism , Carcinoma, Papillary , Diffusion , Humans , Iodine Radioisotopes/metabolism , Male , Middle Aged , Radionuclide Imaging , Thyroid Cancer, Papillary
SELECTION OF CITATIONS
SEARCH DETAIL
...